Want to give Dad the gift of joy? Surprise him with a unique and innovative offering from one of the remarkable companies in our portfolio. FITNESS Epicore Biosystems’ Gx Sweat Patch is a skin-like patch that captures and measures sweat hydration markers in real-time. …

Consumers’ sense of what it means to “look good” keeps shifting, so naturally, the beauty industry must constantly evolve and adapt to fresh demands. This is abundantly true with the emergence of Gen Z, whose digital-first, health-centric, do-no-harm, environmentally-sensitive approach has necessitated a complete rethink of marketing strategies, product offerings…

Where We Are Investing Now: Forward-Thinking Food and Beverage The global Food and Beverage market is huge, growing, and constantly changing. In 2022, the animal protein, snacks, and alcohol markets were valued at around $1.4T each, with coffee and tea at an impressive $650B. Food and drink represent nutrition, pleasure…

As our Managing Partner’s mentor Bill Ziff used to say: “Language is truth.” In other words, the way we describe things actually alters the nature of the reality around us. Such is the case now in our perspective on deep science bio investing. Over the past few decades, the label…

Materials, both those derived from nature and human-created, are essential to products, packaging, technology, and transportation. Modern life isn’t possible without them. Sadly, though, most of them are not healthy for us and many are horrible for the environment. Even materials originally from nature are so altered by modern production…

In a world awash in stress, neurotech that lifts mood, diminishes anxiety, deepens positive behavior and otherwise benefits individuals is supremely important. Even so, in terms of investment, this category faces tough sledding: it takes time for consumers to adopt new tech. That gets even harder during a period of…

Personal health is, and long has been, big business. The US healthcare expenditure reached $4.3 trillion in 2021 and is estimated to reach $6.2 trillion by 2028. The US spent nearly 16.8% GDP on healthcare in 2019 and that will triple to $12 trillion by 2040 or 26% of the…

The time has come, I believe, to move beyond the unicorn. Over recent decades, it has become common cant that the purpose of venture capital is to create unicorns. The more unicorns a fund has, the better it is perceived to be. Unicorns, of course, are mythological and rare and…

Founders and investors are ringing in the new year with a sobering statistic: In 2022, 82.2% of VC funding capital went to startups without a single woman on the founding team. Before I unpack this stat, spoiler alert: Joyance Partners, where I’m an investor, is bucking this trend. …